Marcos de Lima, MD, UH Cleveland Medical Center, Cleveland, OH, provides an outlook on the current CAR T-cell climate including expanding the reach of therapies, determining the best model for manufacturing, and moving towards off-the-shelf therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).